Stocks · News reference
Organigram Maintains Cannabis Market Lead Ahead Of Q3 Results
Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share and a growing global cannabis platform following its acquisition of Sanity
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 20, 2026, 10:05 AM
- Checked
- Jul 20, 2026, 10:05 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Organigram Global shares are trading higher after the company reported better-than-expected Q3 sales results and issued strong FY26 revenue guidance.
Read original at benzingaOrganiGram Holdings Q3 Sales $76.413M Beat $67.660M Estimate
OrganiGram Holdings (NASDAQ:OGI) reported quarterly sales of $76.413 million which beat the analyst consensus estimate of $67.660 million by 12.94 percent. This is a 49.41 percent increase over sales of $51.142 million
Read original at benzingaOrganigram Affirm Global FY2026 Revenue expected to be more than $255.197M vs $241.360M Est
Organigram Global (NASDAQ:OGI) affirm FY2026 Revenue expected to be more than $255.197M vs $241.360M Est
Read original at benzingaOrganigram Global Q3 Sales $105.782M Beat $96.870M Estimate
Organigram Global (TSX:OGI) reported quarterly sales of $105.782 million which beat the analyst consensus estimate of $96.870 million by 9.20 percent. This is a 49.43 percent increase over sales of $70.792 million the
Read original at benzinga